112 related articles for article (PubMed ID: 8353985)
1. Effect of antimicrobial treatment on chronic reactive arthritis.
Toivanen A; Yli-Kerttula T; Luukkainen R; Merilahti-Palo R; Granfors K; Seppälä J
Clin Exp Rheumatol; 1993; 11(3):301-7. PubMed ID: 8353985
[TBL] [Abstract][Full Text] [Related]
2. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.
Sieper J; Fendler C; Laitko S; Sörensen H; Gripenberg-Lerche C; Hiepe F; Alten R; Keitel W; Groh A; Uksila J; Eggens U; Granfors K; Braun J
Arthritis Rheum; 1999 Jul; 42(7):1386-96. PubMed ID: 10403266
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis.
Hoogkamp-Korstanje JA; Moesker H; Bruyn GA
Ann Rheum Dis; 2000 Nov; 59(11):914-7. PubMed ID: 11053072
[TBL] [Abstract][Full Text] [Related]
4. Reactive Arthritis.
Schmitt SK
Infect Dis Clin North Am; 2017 Jun; 31(2):265-277. PubMed ID: 28292540
[TBL] [Abstract][Full Text] [Related]
5. Reactive arthritis: clinical aspects and medical management.
Carter JD; Hudson AP
Rheum Dis Clin North Am; 2009 Feb; 35(1):21-44. PubMed ID: 19480995
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis.
Kuuliala A; Julkunen H; Paimela L; Peltomaa R; Kautiainen H; Repo H; Leirisalo-Repo M
Rheumatol Int; 2013 Nov; 33(11):2723-9. PubMed ID: 23783643
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis.
Wakefield D; McCluskey P; Verma M; Aziz K; Gatus B; Carr G
Arthritis Rheum; 1999 Sep; 42(9):1894-7. PubMed ID: 10513804
[TBL] [Abstract][Full Text] [Related]
8. Are antibiotics of any use in reactive arthritis?
Leirisalo-Repo M
APMIS; 1993 Aug; 101(8):575-81. PubMed ID: 8105815
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter jejuni vertebral osteomyelitis.
Puljiz I; Topic A
Lancet Infect Dis; 2017 Sep; 17(9):1002. PubMed ID: 28845786
[No Abstract] [Full Text] [Related]
10. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.
Yli-Kerttula T; Luukkainen R; Yli-Kerttula U; Möttönen T; Hakola M; Korpela M; Sanila M; Uksila J; Toivanen A
Ann Rheum Dis; 2003 Sep; 62(9):880-4. PubMed ID: 12922963
[TBL] [Abstract][Full Text] [Related]
11. Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin.
Zhang Y; Toivanen A; Toivanen P
Br J Rheumatol; 1997 May; 36(5):541-6. PubMed ID: 9189055
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of Campylobacter infections].
Gracheva NM; Partin OS; Shcherbakov IT; Ivanova VI; Fokin SN
Antibiot Khimioter; 1992 Jun; 37(6):31-5. PubMed ID: 1417342
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of bifidum-containing preparations in enterogenous reactive arthritis].
Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI
Ter Arkh; 1991; 63(5):33-6. PubMed ID: 1887411
[TBL] [Abstract][Full Text] [Related]
14. [Principles of therapy in reactive arthritis].
Braun J; Eggens U; Sieper J
Wien Klin Wochenschr; 1994; 106(9):259-64. PubMed ID: 8023519
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and antibiotic treatment of reactive arthritis].
Sieper J; Braun J
Dtsch Med Wochenschr; 2002 Sep; 127(37):1893-6. PubMed ID: 12226789
[No Abstract] [Full Text] [Related]
16. [Myopericarditis caused by Campylobacter jejuni].
Douchet MP; Dugast S; Zupan M; Christmann D
Presse Med; 1999 Jun; 28(23):1237. PubMed ID: 10420889
[No Abstract] [Full Text] [Related]
17. Reactive arthritis after Campylobacter jejuni enteritis.
van de Putte LB; Berden JH; Boerbooms MT; Muller WH; Rasker JJ; Reynvaan-Groendijk A; van der Linden SM
J Rheumatol; 1980; 7(4):531-5. PubMed ID: 7420335
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
Gupta A; Nelson JM; Barrett TJ; Tauxe RV; Rossiter SP; Friedman CR; Joyce KW; Smith KE; Jones TF; Hawkins MA; Shiferaw B; Beebe JL; Vugia DJ; Rabatsky-Ehr T; Benson JA; Root TP; Angulo FJ;
Emerg Infect Dis; 2004 Jun; 10(6):1102-9. PubMed ID: 15207064
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.
Pichler HE; Diridl G; Stickler K; Wolf D
Am J Med; 1987 Apr; 82(4A):329-32. PubMed ID: 3555057
[TBL] [Abstract][Full Text] [Related]
20. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
Evans MR; Northey G; Sarvotham TS; Rigby CJ; Hopkins AL; Thomas DR
Clin Infect Dis; 2009 Jun; 48(11):1500-6. PubMed ID: 19400688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
